GPP
OPTN

Great Point Partners’s OptiNose OPTN Stock Holding History

Great Point Partners’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-370,269
Closed -$2.47M – 34
2024
Q4 		$2.47M Sell
370,269
-487,140
-57% -$4.29M 1.17% 25
2024
Q3 		$8.62M Sell
857,409
-57,731
-6% -$842K 2.54% 17
2024
Q2 		$14.3M Buy
915,140
+329,385
+56% +$5.52M 2.73% 17
2024
Q1 		$12.8M Sell
585,755
-3,574
-0.6% -$79.3K 2% 22
2023
Q4 		$11.4M Hold
589,329
– – 1.94% 19
2023
Q3 		$10.9M Hold
589,329
– – 1.98% 22
2023
Q2 		$10.9M Buy
589,329
+63,013
+12% +$1.49M 2.13% 19
2023
Q1 		$15.2M Hold
526,316
– – 2.99% 17
2022
Q4 		$14.6M Buy
+526,316
New +$20M 2.86% 14
2020
Q1 		– Sell
-78,789
Closed -$10.9M – 45
2019
Q4 		$10.9M Buy
+78,789
New +$10.2M 0.95% 26

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Great Point Partners's OPTN Position: Q1 2025 in Review

Great Point Partners sold out of OptiNose (OPTN) in Q1 2025, closing a stake of 370,269 shares — an estimated $2.47M sold.

Great Point Partners first reported a position in OPTN in Q4 2019 and held it in 10 quarters. The position peaked at $15.2M in Q1 2023. 43 funds tracked by Wall St. Rank hold OPTN as of Q1 2025.

  • Great Point Partners reported no remaining OptiNose position as of Q1 2025 after selling out during the quarter.
  • Great Point Partners sold 370,269 OptiNose shares in Q1 2025, an estimated $2.47M.
  • Great Point Partners first reported a position in OptiNose in Q4 2019 and held it in 10 quarters.
  • Great Point Partners's OptiNose position peaked at $15.2M in Q1 2023.
  • 43 funds tracked by Wall St. Rank held OptiNose as of Q1 2025.

Based on Great Point Partners's 13F filing for Q1 2025, filed 15 May 2025.